"Executive Summary Hemato Oncology Testing Market Market :  The global hemato oncology testing market was valued at USD 8.13 billion in 2024 and is expected to reach USD 14.83 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.80% , primarily driven by the rising incidence of blood cancers The leading...

"Executive Summary Lung Cancer Screening Software Market Market :  The global lung cancer screening software market size was valued at USD 47.38 billion in 2024 and is expected to reach USD 195.75 billion by 2032, at a CAGR of 19.40% during the forecast period The Lung Cancer Screening Software Market Market research report concentrates on the...

"Executive Summary Nuclear Medicine Equipment Market Market :  The global nuclear medicine equipment market size was valued at USD 2.76 billion in 2024 and is expected to reach USD 4.64 billion by 2032, at a CAGR of 6.70% during the forecast period In this Nuclear Medicine Equipment Market Market report, industry trends are put together on...

"Executive Summary:  The global pelvic cancer drug market size was valued at USD 1.06 billion in 2024 and is projected to reach USD 3.19 billion by 2032, with a CAGR of 14.00% during the forecast period of 2025 to 2032 Pelvic Cancer Drug Market Poised for Strong Growth Driven by Innovation and Evolving Demand The global Pelvic Cancer Drug Market is witnessing accelerated...

Overview of the Brachytherapy Market The Brachytherapy Market is witnessing significant growth driven by the rising global burden of cancer, increasing adoption of minimally invasive cancer treatment procedures, and advancements in radiation therapy technologies. Brachytherapy—also known as internal radiation therapy—involves placing radioactive material directly inside...

"Executive Summary Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market : CAGR Value Data Bridge Market Research analyses that the breast cancer 1 (BRCA1) and breast cancer 2 (BRCA2) genes market, which is USD 5.62 billion in 2022, is expected to reach USD 11.28 billion by 2030, at a CAGR of 9.10% during the forecast period 2023 to 2030. A perfect combination of advanced...

Global Executive Summary Cancer Treatment Market: Size, Share, and Forecast The global cancer treatment market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 12.1% in the forecast period of 2022 to 2029 and is expected to reach USD 524,921.84 million by 2029 from USD 215,900.00...

Executive Summary Tumor Markers Testing Market Size and Share Analysis Report CAGR Value Data Bridge Market Research analyses the tumor markers testing market growth rate in 2023-2030. The expected CAGR of the tumor markers testing market is around 7.70% in the mentioned forecast period. The market was valued at USD 16.7 billion in 2022 and would grow to USD 30.23 billion by 2030...

1. Introduction The Global Embolotherapy Market is rapidly gaining traction as a key segment within interventional radiology and minimally invasive medicine. Embolotherapy refers to a targeted therapeutic procedure in which embolic agents are used to intentionally block blood flow in specific blood vessels. This technique plays a crucial role in the treatment of various conditions...

Lung cancer remains one of the most formidable adversaries in global health, consistently ranking as the leading cause of cancer incidence and mortality worldwide. The sheer scale of its impact – with an estimated 2.48 million new cases and 1.8 million deaths globally in 2022 – underscores the urgent and continuous need for innovation in its diagnosis and treatment. This pressing...

"Latest Insights on Executive Summary HER2 Positive Breast Cancer Treatment Market Share and Size CAGR Value Data Bridge Market Research analyses a growth rate in the global HER2 positive breast cancer treatment market in the forecast period 2022-2029. The expected CAGR of global HER2 positive breast cancer treatment market  is tend to be around 1.50% in the mentioned forecast...

"Detailed Analysis of Executive Summary Europe Glioblastoma Multiforme Treatment Market Size and Share CAGR Value Data Bridge Market Research analyses that  glioblastoma multiforme treatment market will grow at a CAGR of 7.4% during the forecast period of 2022 to 2029. When market research report is brilliant and precise, it proves to be a backbone for the business that helps...

"Executive Summary Lung Cancer Screening Software Market Size, Share, and Competitive Landscape The global lung cancer screening software market size was valued at USD 47.38 billion in 2024 and is expected to reach USD 195.75 billion by 2032, at a CAGR of 19.40% during the forecast period. To attain knowhow of market landscape, brand awareness, latest...

Cancer, a formidable global health challenge, continues to drive intense research and development for more effective and less toxic therapies. Enter nanotechnology – a revolutionary field operating at the atomic and molecular scale – that is fundamentally transforming the landscape of cancer treatment. By precisely engineering materials at the nanoscale (1 to 100 nanometers),...

Executive Summary New Zealand Clinical Oncology Next Generation Sequencing Market Size and Share Across Top Segments CAGR Value New Zealand clinical oncology next generation sequencing market size was valued at USD 4.12 million in 2024 and is projected to reach USD 14.83 million by 2032, with a CAGR of 17.4% during the forecast period of 2025 to 2032.  This New Zealand...

Regional Overview of Executive Summary Pet Cancer Therapeutics Market by Size and Share The global pet cancer therapeutics market size was valued at USD 309.69 Million in 2024 and is expected to reach USD 621.62 Million by 2032, at a CAGR of 9.10% during the forecast period. Pet Cancer Therapeutics Market analysis gives a clear idea on various...

Introduction The Global Transarterial Chemoembolization (TACE) Market is witnessing substantial growth as healthcare systems across the world increasingly adopt interventional oncology solutions for liver cancer treatment. TACE is a minimally invasive procedure designed to deliver chemotherapy drugs directly to a tumor while restricting its blood supply. This dual-action...

"Executive Summary Hepatocellular Carcinoma Drugs Market: Share, Size & Strategic Insights CAGR Value The global hepatocellular carcinoma drugs market was valued at USD 1.21 billion in 2024 and is expected to reach USD 2.27 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 8.20%, primarily driven by...